Todd Foley's Net Worth

$598 Million

Estimate Recalculated Feb 21, 2024 07:10PM EST

Who is Todd Foley?

Todd Foley has an estimated net worth of $598 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., iTeos Therapeutics, Inc., TriVascular Technologies, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Dyne Therapeutics, Inc., Celladon Corp, Verastem, Inc., Syndax Pharmaceuticals Inc, Harpoon Therapeutics, Inc., ARATANA THERAPEUTICS, INC., TCR2 THERAPEUTICS INC., Conatus Pharmaceuticals Inc, TURMERIC ACQUISITION CORP., Epizyme, Inc., Werewolf Therapeutics, Inc., Cerecor Inc., Oncorus, Inc., Radius Health, Inc., Zalicus Inc., CHIASMA, INC, and Pacira Pharmaceuticals, Inc..

SEC CIK

Todd Foley's CIK is 0001473930

Past Insider Trading and Trends

2020 was Todd Foley's most active year for acquiring shares with 29 total transactions. Todd Foley's most active month to acquire stocks was the month of June. 2021 was Todd Foley's most active year for disposing of shares, totalling 158 transactions. Todd Foley's most active month to dispose stocks was the month of May. 2019 saw Todd Foley paying a total of $14,121,250.25 for 8,086,849 shares, this is the most they've acquired in one year. In 2021 Todd Foley cashed out on 61,795,693 shares for a total of $94,405,436.05, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TriVascular Technologies, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.78M
1.78M
Apr 22
Form 3
0
0
No matching records found

Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.95M
4.95M
Sep 21
Form 3
0
0
No matching records found

Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.565

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.17M
2.17M
Mar 8
Form 3
0
0
No matching records found

ARATANA THERAPEUTICS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.90%
-600.00K
$20.02
-$12,012,000.00
2.75M
Mar 10
Form 4
-100.00%
-12.54K
$19.95
-$250,153.05
0
Mar 7
Form 4
-19.93%
-872.70K
3.51M
Mar 3
Form 4
+944.84%
3.93M
$6.00
4.35M
Jul 2
Form 3
0
0
No matching records found

Conatus Pharmaceuticals Inc (HSTO) Snapshot price: $0.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found